amodiaquine has been researched along with favipiravir in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bavari, S; Besch, R; Duplantier, AJ; Jay, WB; Kota, KP; Kuehl, K; Lazić, M; Mudhasani, R; Panchal, RG; Pavić, A; Retterer, C; Sean, VA; Selaković, Ž; Šolaja, BA; Soloveva, V; Tran, JP; Vasiljević, B; Verbić, T | 1 |
Arima, N; Baba, M; Okamoto, M; Saijo, M; Sakakibara, N; Toyama, M | 1 |
Adhikari, NKJ; Bah, EI; Chan, A; Fowler, RA; Hajek, J; Kao, R; Kiiza, P; Kwon, HY; Lamah, MC; Lamontagne, F; Lee, JS; Mishra, S; Murthy, S; Siemieniuk, R; Teo, K | 1 |
Tsanni, A | 1 |
1 review(s) available for amodiaquine and favipiravir
Article | Year |
---|---|
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Topics: Amides; Amodiaquine; Antibodies, Monoclonal; Antiviral Agents; Artemisinins; Databases, Factual; Drug Combinations; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Pyrazines; Randomized Controlled Trials as Topic | 2019 |
3 other study(ies) available for amodiaquine and favipiravir
Article | Year |
---|---|
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface-Active Agents; Virus Internalization; Zebrafish | 2019 |
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.
Topics: Amides; Amodiaquine; Animals; Antiviral Agents; Bunyaviridae; Bunyaviridae Infections; Cell Line; Chlorocebus aethiops; Fever; Humans; Microbial Sensitivity Tests; Pyrazines; Ribavirin; Thrombocytopenia; Virus Replication | 2017 |
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |